Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue guidance of $1.36 billion at the midpoint came in 2.7% below analysts’ estimates. Its non-GAAP profit of $1.34 per share was 11.4% above analysts’ consensus estimates.
Semiconductor production equipment provider Amtech Systems (NASDAQ:ASYS) announced better-than-expected revenue in Q4 CY2024, but sales fell by 2.1% year on year to $24.39 million. On the other hand, next quarter’s revenue guidance of $22 million was less impressive, coming in 14.1% below analysts’ estimates. Its non-GAAP profit of $0.02 per share was significantly above analysts’ consensus estimates.
Wireless chipmaker Qualcomm (NASDAQ:QCOM) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 17.5% year on year to $11.67 billion. On top of that, next quarter’s revenue guidance ($10.75 billion at the midpoint) was surprisingly good and 4.2% above what analysts were expecting. Its non-GAAP profit of $3.41 per share was 14.9% above analysts’ consensus estimates.
Old Dominion Freight Line is planning for a good 2025 back half and hasn’t given up on the first half yet. The post Old Dominion poised to take share when market turns appeared first on FreightWaves.
Wireless chips maker Skyworks Solutions (NASDAQ: SWKS) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 11.1% year on year to $1.07 billion. The company expects next quarter’s revenue to be around $950 billion, coming in 100,716% above analysts’ estimates. Its non-GAAP profit of $1.60 per share was 1.7% above analysts’ consensus estimates.
Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the other hand, next quarter’s revenue guidance of $1 billion was less impressive, coming in 3.2% below analysts’ estimates. Its non-GAAP profit of $1.03 per share was 1.4% above analysts’ consensus estimates.
Semiconductor testing company FormFactor (NASDAQ:FORM) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 12.7% year on year to $189.5 million. On the other hand, next quarter’s revenue guidance of $170 million was less impressive, coming in 11.6% below analysts’ estimates. Its non-GAAP profit of $0.27 per share was 7.3% below analysts’ consensus estimates.
Engineering and design software provider PTC (NASDAQ:PTC) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 2.7% year on year to $565.1 million. On the other hand, next quarter’s revenue guidance of $605 million was less impressive, coming in 5.8% below analysts’ estimates. Its GAAP profit of $0.68 per share was 26.6% above analysts’ consensus estimates.
Alphabet shares fell sharply Wednesday as investors responded to the Google parent's weaker-than-expected revenue numbers and big AI spending plans. Monitor these important chart levels.
Palantir stock is trading at a lofty valuation "which history suggests is nearly impossible to grow into," Deutsche Bank's Brad Zelnick said.
